Trevena Inc. (TRVN) Fundamentals

Trevena Inc is an American biotechnology company. The portfolio pipeline is focused on medicines targeting pain management: TRV734: oral medicine for moderate to severe pain; TRV250: oral medicine for migraines; and TRV027: treatment for acute heart failure. Its leading product is oliceridine (TRV130), a protein-based chemical meant to manage moderate to severe acute pain.
SHARE INFORMATION
Market Cap$ 28,605,275
Shares Outstanding173,681,085
Float171,930,678
Percent Float98.99%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 567,000
Latest Fiscal EPS$ -0.32
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions182
Institutional Holdings Date2022-09-30
Institutional Bought Previous 3 Months3,934,761
Institutional Holdings Percent25.4%
Institutional Sold Previous 3 Months20,439,105
Insider Holdings Date2022-09-30
Insider Bought Previous 3 Months-
Insider Holdings Percent3.3
Insider Sold Previous 3 Months1,792
Insider Shares Owned5,660,358
TRADING INFO
52 Week High$ 1.27
52 Week Low$ 0.15
52 Week High Change$ -86.72
21 Day Moving Average$ 0.1815
21 Day Extended Moving Average$ 0.179154
50 Day Moving Average$ 0.2098
50 Day Extended Moving Average$ 0.216609
200 Day Moving Average$ 0.377971
200 Day Extended Moving Average$ 0.451871
10 Day Average Volume573,741
20 Day Average Volume610,348
30 Day Average Volume596,531
50 Day Average Volume986,016
Alpha-0.018021
Beta1.8270
Standard Deviation0.317341
R20.090111
7 Day Price Change$ 0.0119
7 Day Percent Change7.79%
21 Day Price Change$ -0.0442
21 Day Percent Change-21.16%
30 Day Price Change$ -0.0412
30 Day Percent Change-20.01%
Month to Date Price Change$ 0.0115
Month to Date Percent Change7.51%
Quarter to Date Price Change$ 0.0115
Quarter to Date Percent Change7.51%
180 Day Price Change$ -0.3031
180 Day Percent Change-64.79%
200 Day Price Change$ -0.3753
200 Day Percent Change-69.5%
Year to Date Price Change$ -0.4178
Year to Date Percent Change-71.73%

Trevena Inc. (TRVN) Key Ratios

PROFITABILITY
EBIT Margin-29,384.0%
EBITDA Margin-29,172.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin-378.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 19,000
Revenue Per Share$ 0.0001
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.80
Total Debt To Equity0.60
Int Coverage-180.30
Current Ratio5.90
Leverage Ratio1.60
Quick Ratio5.20
Long Term Debt To Capital0.35
VALUATION MEASURES
PE Ratio-0.40
Enterprise Value$ -2,065,070
Price to Sales1,505.5408
Price to Free Cash-0.60
PE High Last 5 Years-3.00
Price To Book0.80
Price To Cash Flow0.00
PE Low Last 5 Years-2.30
Price to Tangible Book0.80
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.50
Assets Turnover0.00
Return Assets-72.09
Return on Equity-101.95
Return on Capital-76.52

Trevena Inc. (TRVN) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEOCarrie L. Bourdow
Emplyoees43
Last AuditUE
CIK0001429560
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address955 Chesterbrook Boulevard
Suite 110
Chesterbrook, PA 19087
Websitehttps://www.trevena.com
Facsimile-
Telephone+1 610 354-8840
EmailIR@trevenainc.com


Your Recent History
NASDAQ
TRVN
Trevena
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.